NEUROPACE, INC. Financing Cash Flow
NEUROPACE, INC. (NPCE) reported Financing Cash Flow of $1.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-11
- NEUROPACE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.18M.
- NEUROPACE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$166.00K, a 100.79% decline year-over-year.
- NEUROPACE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $635.00K, a 25.12% decline year-over-year.
- NEUROPACE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$235.00K, a 108.11% decline year-over-year.
- NEUROPACE, INC. net cash provided by (used in) financing activities for fiscal 2025 was $19.60M, a 352.97% increase from fiscal 2024.
- NEUROPACE, INC. net cash provided by (used in) financing activities for fiscal 2024 was $4.33M, a 46.76% decline from fiscal 2023.
- NEUROPACE, INC. net cash provided by (used in) financing activities for fiscal 2023 was $8.13M, a 1558.57% increase from fiscal 2022.
- NEUROPACE, INC. net cash provided by (used in) financing activities for fiscal 2022 was $490.00K, a 99.52% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.01M 10-Q · filed 2026-08-11 | $1.65M derived: sum of 3 quarters · filed 2026-08-11 | $1.41M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$166.00K 10-Q · filed 2026-05-12 | $469.00K derived: sum of 2 quarters · filed 2026-05-12 | $234.00K derived: sum of 3 quarters · filed 2026-05-12 | -$1.67M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $400.00K derived: sum of 2 quarters · filed 2026-03-03 | -$1.51M derived: sum of 3 quarters · filed 2026-08-11 | $19.60M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.14M derived: sum of 2 quarters · filed 2026-08-11 | $18.96M 10-Q · filed 2025-11-04 | $19.81M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $19.20M 10-Q · filed 2026-08-11 | $20.05M derived: sum of 3 quarters · filed 2026-08-11 | $22.95M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $21.11M 10-Q · filed 2026-05-12 | $21.96M derived: sum of 2 quarters · filed 2026-05-12 | $24.85M derived: sum of 3 quarters · filed 2026-05-12 | $25.36M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $848.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.75M derived: sum of 2 quarters · filed 2026-03-03 | $4.25M derived: sum of 3 quarters · filed 2026-03-03 | $4.33M 10-K · filed 2026-03-03 |
| 2024-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.41M derived: sum of 2 quarters · filed 2025-11-04 | $3.48M 10-Q · filed 2025-11-04 | $11.69M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $581.00K 10-Q · filed 2025-08-12 | $8.79M derived: sum of 3 quarters · filed 2025-08-12 | $8.77M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $72.00K 10-Q · filed 2025-05-13 | $8.29M derived: sum of 2 quarters · filed 2025-05-13 | $8.26M derived: sum of 3 quarters · filed 2025-05-13 | $8.45M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $8.19M derived: sum of 2 quarters · filed 2025-03-04 | $8.38M derived: sum of 3 quarters · filed 2025-03-04 | $8.13M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $168.00K derived: sum of 2 quarters · filed 2024-11-12 | -$87.00K 10-Q · filed 2024-11-12 | -$225.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$60.00K 10-Q · filed 2024-08-13 | -$198.00K derived: sum of 3 quarters · filed 2024-08-13 | -$206.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$255.00K 10-Q · filed 2024-05-08 | -$393.00K derived: sum of 2 quarters · filed 2024-05-08 | -$401.00K derived: sum of 3 quarters · filed 2024-05-08 | $234.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$146.00K derived: sum of 2 quarters · filed 2024-03-05 | $489.00K derived: sum of 3 quarters · filed 2024-03-05 | $490.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $627.00K derived: sum of 2 quarters · filed 2023-11-06 | $628.00K 10-Q · filed 2023-11-06 | $1.54M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $635.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $636.00K 10-Q · filed 2023-08-08 | $1.55M derived: sum of 3 quarters · filed 2023-08-08 | $1.55M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-04 | $912.00K derived: sum of 2 quarters · filed 2023-05-04 | $912.00K derived: sum of 3 quarters · filed 2023-05-04 | $104.11M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $911.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $911.00K derived: sum of 2 quarters · filed 2023-03-02 | $104.10M derived: sum of 3 quarters · filed 2023-03-02 | $102.53M 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $103.19M derived: sum of 2 quarters · filed 2022-11-08 | $101.61M 10-Q · filed 2022-11-08 | $101.34M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $103.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $101.61M 10-Q · filed 2022-08-11 | $101.34M derived: sum of 3 quarters · filed 2022-08-11 | $140.15M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.58M 10-Q · filed 2022-05-12 | -$1.86M derived: sum of 2 quarters · filed 2022-05-12 | $36.96M derived: sum of 3 quarters · filed 2022-05-12 | $40.91M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $38.54M derived: sum of 2 quarters · filed 2022-03-10 | $42.49M derived: sum of 3 quarters · filed 2022-03-10 | $55.01M 10-K · filed 2022-03-10 |
| 2020-09-30 | $38.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $42.77M derived: sum of 2 quarters · filed 2021-11-10 | $55.29M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $16.47M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $12.52M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |